Skip to main content
. 2017 Jul 26;14(4):4349–4354. doi: 10.3892/ol.2017.6678

Figure 3.

Figure 3.

Elacridar recovered sensitivity to docetaxel. Docetaxel resistant cells were treated with DMSO, elacridar (0.25 µg/ml) only, or elacridar (0.25 µg/ml) combined with 100 nM of docetaxel for 48 h, and lysates were subjected to western blot analysis with the indicated antibodies.